Aviva, which recently updated its critical illness cover to reflect the Association of British Insurers' (ABI) model wordings updates, has extended the changes for both its business and direct-to-consumer (D2C) plans.
The provider updated its core and critical illness plans in September in accordance with the ABI's amended definitions for cancer, dementia and heart attack. ABI members have until 16 September 2023 to make amendments to their respective plans. As part of the updates, Aviva has removed "less advanced" prostate cancer from its cancer definition but said it will still be included if treated by prostatectomy. However, due to the definition change, it will be removed from the less advanced cancer of the prostate definition which will result in a marginal increase to future cancer claims. ...
To continue reading this article...
Join COVER for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
